Prognostic Factors in Patients with Nasopharyngeal Carcinoma

Authors

  • Stein Kaasa Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo
  • Erik Kragh-Jensen Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo
  • Kristin Bjordal Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo
  • Eiliv Lund Department of Community Medicine, Tromsø University, Tromsø
  • Jan F. Evensen Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo
  • Halvor Vermund Eastern Carolina School of Medicine, Greenville, North Carolina, USA
  • Odd Monge Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo
  • Per `Boehler Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway

DOI:

https://doi.org/10.3109/02841869309096113

Abstract

From 1971 to 1985 a total of 122 patients with non-distant metastatic nasopharyngeal carcinoma were treated at the Norwegian Radium Hospital with radiation doses that increased from 50 Gy (at 2 Gy/fractions) to 70 Gy (at 2 Gy/fractions) during the treatment period. Possible relationship between the increase in dose and survival time was investigated. The median cancer-specific survival time was 50 months, and the median crude survival time 38 months. No correlation was found between radiation dose and survival time. In a multivariate analysis histology was found to be the most important prognostic factor for survival with a relative risk of death from cancer of 3.4 and 3.2 for non-keratiniz-ing carcinoma and squamous cell carcinoma respectively compared with undifferentiated carcinoma. When assessed in terms of N category the relative death risk for N2/N3 was 2.1 compared to N0/Nl.

Downloads

Download data is not yet available.

Downloads

Published

1993-01-01

How to Cite

Kaasa, S. ., Kragh-Jensen, E. ., Bjordal, K. ., Lund, E. ., Evensen, J. F. ., Vermund, H. ., … `Boehler, P. . (1993). Prognostic Factors in Patients with Nasopharyngeal Carcinoma. Acta Oncologica, 32(5), 531–536. https://doi.org/10.3109/02841869309096113